Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC35325106198;106199;106200 chr2:178530642;178530641;178530640chr2:179395369;179395368;179395367
N2AB33684101275;101276;101277 chr2:178530642;178530641;178530640chr2:179395369;179395368;179395367
N2A3275798494;98495;98496 chr2:178530642;178530641;178530640chr2:179395369;179395368;179395367
N2B2626079003;79004;79005 chr2:178530642;178530641;178530640chr2:179395369;179395368;179395367
Novex-12638579378;79379;79380 chr2:178530642;178530641;178530640chr2:179395369;179395368;179395367
Novex-22645279579;79580;79581 chr2:178530642;178530641;178530640chr2:179395369;179395368;179395367
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAA
  • RefSeq wild type template codon: TTT
  • Domain: Ig-165
  • Domain position: 40
  • Structural Position: 56
  • Q(SASA): 0.4783
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/E None None 0.089 N 0.547 0.266 0.321672782286 gnomAD-4.0.0 6.84134E-07 None None None None N None 0 0 None 0 0 None 0 0 8.99391E-07 0 0
K/Q None None 0.407 N 0.6 0.225 0.32053947749 gnomAD-4.0.0 6.84134E-07 None None None None N None 0 0 None 0 0 None 0 0 8.99391E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.4336 ambiguous 0.3728 ambiguous -0.366 Destabilizing 0.206 N 0.57 neutral None None None None N
K/C 0.7798 likely_pathogenic 0.7385 pathogenic -0.541 Destabilizing 0.955 D 0.659 neutral None None None None N
K/D 0.7955 likely_pathogenic 0.731 pathogenic 0.065 Stabilizing 0.476 N 0.631 neutral None None None None N
K/E 0.2531 likely_benign 0.2158 benign 0.174 Stabilizing 0.089 N 0.547 neutral N 0.425025215 None None N
K/F 0.8091 likely_pathogenic 0.7651 pathogenic -0.111 Destabilizing 0.874 D 0.651 neutral None None None None N
K/G 0.6792 likely_pathogenic 0.6031 pathogenic -0.685 Destabilizing 0.476 N 0.527 neutral None None None None N
K/H 0.4724 ambiguous 0.4122 ambiguous -0.733 Destabilizing 0.874 D 0.621 neutral None None None None N
K/I 0.295 likely_benign 0.2622 benign 0.443 Stabilizing 0.582 D 0.671 neutral N 0.474128671 None None N
K/L 0.3289 likely_benign 0.2891 benign 0.443 Stabilizing 0.476 N 0.527 neutral None None None None N
K/M 0.2091 likely_benign 0.1861 benign -0.01 Destabilizing 0.955 D 0.616 neutral None None None None N
K/N 0.5127 ambiguous 0.4381 ambiguous -0.331 Destabilizing 0.407 N 0.593 neutral N 0.507201094 None None N
K/P 0.5927 likely_pathogenic 0.5708 pathogenic 0.202 Stabilizing 0.648 D 0.627 neutral None None None None N
K/Q 0.1703 likely_benign 0.1488 benign -0.317 Destabilizing 0.407 N 0.6 neutral N 0.477147546 None None N
K/R 0.1113 likely_benign 0.1029 benign -0.278 Destabilizing 0.001 N 0.253 neutral N 0.465815832 None None N
K/S 0.5972 likely_pathogenic 0.5134 ambiguous -0.895 Destabilizing 0.206 N 0.579 neutral None None None None N
K/T 0.2542 likely_benign 0.2175 benign -0.591 Destabilizing 0.407 N 0.585 neutral N 0.501640559 None None N
K/V 0.331 likely_benign 0.294 benign 0.202 Stabilizing 0.476 N 0.619 neutral None None None None N
K/W 0.8552 likely_pathogenic 0.8219 pathogenic -0.081 Destabilizing 0.955 D 0.673 neutral None None None None N
K/Y 0.6779 likely_pathogenic 0.6201 pathogenic 0.212 Stabilizing 0.648 D 0.619 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.